Clinical trial
Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response…
NCT00322725 · University of New Mexico, Other · Terminated
Key facts
| NCT number | NCT00322725 |
|---|---|
| Title | Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review |
| Official title | Bevacizumab(Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review |
| Lead sponsor | University of New Mexico, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Cancer |
| Enrollment | 25 |
| Start date | Feb 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | May 8, 2006 |
| Last update posted | Jan 11, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: